MYC and Miyoshi myopathy: Concordantly, among 599 MM patients in the CoMMpass study (NCT01454297), those carrying del(17p) and/or TP53 mutations exhibited higher copy number changes and TMB compared with the remaining patients (Fig. 3b), indicating that TP53-driven genetic instability promotes genetic rearrangements including those involving MYC during MM progression.